Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	2.16B	2.20B	2.15B	1.94B	1.78B
Total	2.16B	2.20B	2.15B	1.94B	1.78B

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other Countries	67.60M	64.31M	54.45M	34.82M	26.62M
Taiwan	1.70B	1.61B	1.42B	1.31B	1.17B
Mainland China	209.24M	239.74M	407.41M	184.15M	362.60M
Japan	101.06M	190.08M	207.07M	240.93M	95.64M
United States	81.45M	93.24M	60.37M	174.14M	122.59M
Total	2.16B	2.20B	2.15B	1.94B	1.78B

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error